532139-2026 - Competition
Finland – Medical equipments, pharmaceuticals and personal care products – Test for amino acids in plasma and urine
OJ S 146/2026 31/07/2026
Contract or concession notice – standard regime
Supplies
1. Buyer
1.1.
Buyer
Official nameHUS Group
Emailkilpailutus.diagnostiikka@hus.fi
Legal type of the buyerRegional authority
Activity of the contracting authorityHealth
2. Procedure
2.1.
Procedure
TitleTest for amino acids in plasma and urine
DescriptionThe HUS Group requests tenders to procure test kit(s) for plasma and urine amino acids by liquid chromatography tandem mass spectrometry (LC-MS/MS) based technology. The test kit(s) should contain all needed assay dependent products like reagents, calibrators, the manufacturer’s control samples, the method parameters for the LC-MS/MS instrumentation, product support and all other products needed for the assay except ordinary laboratory necessity, e.g. laboratory water, pipettes or glassware. The products are described in more detail in below in the invitation to tender. This is a total procurement, i.e. the procurement is not divided into lots. The offered solution must cover both plasma and urine testing. At present, the instrumentation available at HUS comprises LC from Shimadzu (Nexera 30 or 40) and MS/MS instruments from AB Sciex (5500+ Triple Quadrupole or Citrine) with Analyst MD 1.6.3. Hotfix 4 or SCIEX OS software versions. In addition, basic laboratory instrumentation like mixers, incubators, pipetting robots and centrifuges are available. The kits are intended for the detection and quantitative analysis of amino acids in plasma and urine. The amino acid profile allows diagnosis and monitoring of inborn errors of metabolism. At present, HUS runs approximately 1000 plasma and 200 urine patient sample tests yearly. The runs are performed in approximately 2-3 batches a week and about 5-10 samples in one batch. Samples should be able to prepare in vials. The contract period is 48 months. ESTIMATED VALUE At present, HUS runs approximately 1000 plasma and 200 urine patient sample tests yearly. This is an estimate and the contracting entity does not commit to the stated consumption figures indicated in the invitation to tender. The final order quantities may be higher or lower than stated. The subject matter and requirements of the procurement are described in detail in the invitation to tender and its annexes.
Procedure identifier51845076-1adc-462a-81bc-17fc2247b8c9
Internal identifierHUS 641-2024
Type of procedureOpen
The procedure is acceleratedno
Main features of the procedureThe procurement shall comply with the Act on Public Procurement and Concession Contracts (1397/2016, referred to as the Public Procurement Act). The procurement value exceeds the EU threshold value. The procedure shall be an open procedure as defined in section 32 of the Public Procurement Act. PROCESSING OF TENDERS The procedure shall include the following phases: Contracting entity 1. Opens the tenders 2. Verifies the suitability of the tenderer 3. Checks that the tenders conform to the invitation to tender 4. Compares the tenders 5. Requests and checks certificates and reports on the suitability of the winning tenderer(s) 6. Makes a procurement decision and communicates it to all the tenderers 7. Concludes an agreement with the selected tenderer(s) LANGUAGE OF THE COMPETITIVE TENDERING PROCEDURE The procurement documents are available in English. If a tenderer needs the documents in another language, the tenderer shall be responsible for translation and liable for the associated costs. Tenders must be prepared in English. PARTIAL TENDERS Partial tenders will not be accepted. PARALLEL TENDERS Parallel tenders are not permitted.
2.1.1.
Purpose
Main nature of the contractSupplies
Main classification (cpv): 33000000 Medical equipments, pharmaceuticals and personal care products
2.1.2.
Place of performance
CountryFinland
Anywhere in the given country
2.1.4.
General information
Legal basis
Directive 2014/24/EU
2.1.6.
Grounds for exclusion
Sources of grounds for exclusionEuropean Single Procurement Document (ESPD)
5. Lot
5.1.
LotLOT-0000
TitleTest for amino acids in plasma and urine
DescriptionThe HUS Group requests tenders to procure test kit(s) for plasma and urine amino acids by liquid chromatography tandem mass spectrometry (LC-MS/MS) based technology. The test kit(s) should contain all needed assay dependent products like reagents, calibrators, the manufacturer’s control samples, the method parameters for the LC-MS/MS instrumentation, product support and all other products needed for the assay except ordinary laboratory necessity, e.g. laboratory water, pipettes or glassware. The products are described in more detail in below in the invitation to tender. This is a total procurement, i.e. the procurement is not divided into lots. The offered solution must cover both plasma and urine testing. At present, the instrumentation available at HUS comprises LC from Shimadzu (Nexera 30 or 40) and MS/MS instruments from AB Sciex (5500+ Triple Quadrupole or Citrine) with Analyst MD 1.6.3. Hotfix 4 or SCIEX OS software versions. In addition, basic laboratory instrumentation like mixers, incubators, pipetting robots and centrifuges are available. The kits are intended for the detection and quantitative analysis of amino acids in plasma and urine. The amino acid profile allows diagnosis and monitoring of inborn errors of metabolism. At present, HUS runs approximately 1000 plasma and 200 urine patient sample tests yearly. The runs are performed in approximately 2-3 batches a week and about 5-10 samples in one batch. Samples should be able to prepare in vials. The contract period is 48 months. ESTIMATED VALUE At present, HUS runs approximately 1000 plasma and 200 urine patient sample tests yearly. This is an estimate and the contracting entity does not commit to the stated consumption figures indicated in the invitation to tender. The final order quantities may be higher or lower than stated. The subject matter and requirements of the procurement are described in detail in the invitation to tender and its annexes.
Internal identifierHUS 641-2024
5.1.1.
Purpose
Main nature of the contractSupplies
Main classification (cpv): 33000000 Medical equipments, pharmaceuticals and personal care products
5.1.2.
Place of performance
CountryFinland
Anywhere in the given country
5.1.3.
Estimated duration
Duration48 Months
5.1.6.
General information
Reserved participation
Participation is not reserved.
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA)yes
This procurement is also suitable for small and medium-sized enterprises (SMEs)yes
5.1.9.
Selection criteria
Sources of selection criteriaEuropean Single Procurement Document (ESPD)
5.1.10.
Award criteria
Criterion
TypePrice
NameKokonaishinta
DescriptionHinta
Category of award weight criterionWeight (points, exact)
Award criterion number1
5.1.11.
Procurement documents
Deadline for requesting additional information19/08/2026 09:00:00 (UTC+00:00) Western European Time, GMT
Address of the procurement documentshttps://tarjouspalvelu.fi/huslogistiikka?id=613485&tpk=23c0cfb4-9783-4e5c-966e-9af385ba6a7e
5.1.12.
Terms of procurement
Terms of submission
Electronic submissionRequired
Address for submissionhttps://tarjouspalvelu.fi/huslogistiikka?id=613485&tpk=23c0cfb4-9783-4e5c-966e-9af385ba6a7e
Languages in which tenders or requests to participate may be submittedEnglish
Electronic catalogueNot allowed
Tenderers may submit more than one tenderNot allowed
Deadline for receipt of tenders31/08/2026 09:00:00 (UTC+00:00) Western European Time, GMT
Duration during which the tender must remain valid9 Months
Information about public opening
Opening date31/08/2026 09:15:00 (UTC+00:00) Western European Time, GMT
Terms of contract
The execution of the contract must be performed within the framework of sheltered employment programmesNo
A non-disclosure agreement is requiredno
Electronic invoicingRequired
Electronic ordering will be usedyes
Electronic payment will be usedyes
5.1.15.
Techniques
Framework agreement
No framework agreement
Information about the dynamic purchasing system
No dynamic purchase system
5.1.16.
Further information, mediation and review
Review organisationMarkkinaoikeus
Information about review deadlines: Precise information about the deadlines for the appeal procedure will be provided in the procurement decision.
Organisation providing more information on the review proceduresHUS Group
8. Organisations
8.1.
ORG-0001
Official nameMarkkinaoikeus
Registration number3006157-6
Postal addressRadanrakentajantie 5
TownHelsinki
Postcode00520
Country subdivision (NUTS)Helsinki-Uusimaa (FI1B1)
CountryFinland
Emailmarkkinaoikeus@oikeus.fi
Telephone+358 295643300
Internet addresshttp://www.oikeus.fi/markkinaoikeus
Roles of this organisation
Review organisation
8.1.
ORG-0002
Official nameHUS Group
Registration number1567535-0
Postal addressUutistie 5 (PO Box 441, 00029 HUS)
TownVantaa
Postcode01770
Country subdivision (NUTS)Helsinki-Uusimaa (FI1B1)
CountryFinland
Contact pointInvestments and diagnostics category
Emailkilpailutus.diagnostiikka@hus.fi
Telephone+358 94711
Internet addresshttp://www.hus.fi
Roles of this organisation
Buyer
Organisation providing more information on the review procedures
8.1.
ORG-0003
Official nameHansel Oy (Hilma)
Registration numberFI09880841
Postal addressMannerheiminaukio 1a
TownHelsinki
Postcode00100
Country subdivision (NUTS)Helsinki-Uusimaa (FI1B1)
CountryFinland
Contact pointeSender
Emailtekninen@hankintailmoitukset.fi
Telephone029 55 636 30
Internet addresshttp://hankintailmoitukset.fi
Roles of this organisation
TED eSender
Notice information
Notice identifier/versionb3ad80ea-542b-4493-96ba-12c17e306869  -  01
Form typeCompetition
Notice typeContract or concession notice – standard regime
Notice subtype16
Notice dispatch date30/07/2026 06:28:41 (UTC+00:00) Western European Time, GMT
Notice dispatch date (eSender)30/07/2026 06:28:42 (UTC+00:00) Western European Time, GMT
Languages in which this notice is officially availableEnglish
Notice publication number532139-2026
OJ S issue number146/2026
Publication date31/07/2026